PRICE INQUIRY No. 19 - being conducted as a market assessment study - amendment to the content - cancelled
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a quotation for services involving the development, manufacture and delivery of an active substance in the form of a modified oligonucleotide – an 18-mer RNA and technology transfer to a designated manufacturing site.. Details of the price inquiry can be found in the documents attached below.
go back